Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keagan P Collins

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|February 14, 2018
Hydroxychloroquine: A Physiologically-Based Pharmacokinetic Model in the Context of Cancer-Related Autophagy ModulationKeagan P Collins, Kristen M Jackson, Daniel L Gustafson
Cancer Chemotherapy and Pharmacology|January 4, 2025
Landscape analysis of adverse events and dose intensity for FDA approved oncology small moleculesKeagan P Collins, Donghua Yin, Yazdi K Pithavala, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 11, 2020
Lysosomal Biogenesis and Implications for Hydroxychloroquine DispositionKeagan P Collins, Sandra Witta, Jonathan W Coy, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 21, 2018
Kinetics of Cyclophosphamide Metabolism in Humans, Dogs, Cats, and Mice and Relationship to Cytotoxic Activity and PharmacokineticsDominique A Ramirez, Keagan P Collins, Allister E Aradi, et al.
Pharmacology Research & Perspectives|January 12, 2023
Vinblastine pharmacokinetics in mouse, dog, and human in the context of a physiologically based model incorporating tissue-specific drug binding, transport, and metabolismSandra Witta, Keagan P Collins, Dominique A Ramirez, et al.
Cancer Chemotherapy and Pharmacology|July 15, 2021
Prospective clinical trial testing COXEN-based gene expression models of chemosensitivity in dogs with spontaneous osteosarcomaDaniel L Gustafson, Keagan P Collins, Jared S Fowles, et al.
G3 (Bethesda, Md.)|October 3, 2019
Genomics Analysis of L-DOPA Exposure in <i>Drosophila sechellia</i>Stephen M Lanno, Ivy Lam, Zachary Drum, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
The Journal of Pharmacology and Experimental Therapeutics|February 14, 2018
Hydroxychloroquine: A Physiologically-Based Pharmacokinetic Model in the Context of Cancer-Related Autophagy ModulationKeagan P Collins, Kristen M Jackson, Daniel L Gustafson
Cancer Chemotherapy and Pharmacology|January 4, 2025
Landscape analysis of adverse events and dose intensity for FDA approved oncology small moleculesKeagan P Collins, Donghua Yin, Yazdi K Pithavala, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 11, 2020
Lysosomal Biogenesis and Implications for Hydroxychloroquine DispositionKeagan P Collins, Sandra Witta, Jonathan W Coy, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 21, 2018
Kinetics of Cyclophosphamide Metabolism in Humans, Dogs, Cats, and Mice and Relationship to Cytotoxic Activity and PharmacokineticsDominique A Ramirez, Keagan P Collins, Allister E Aradi, et al.
Pharmacology Research & Perspectives|January 12, 2023
Vinblastine pharmacokinetics in mouse, dog, and human in the context of a physiologically based model incorporating tissue-specific drug binding, transport, and metabolismSandra Witta, Keagan P Collins, Dominique A Ramirez, et al.
Cancer Chemotherapy and Pharmacology|July 15, 2021
Prospective clinical trial testing COXEN-based gene expression models of chemosensitivity in dogs with spontaneous osteosarcomaDaniel L Gustafson, Keagan P Collins, Jared S Fowles, et al.
G3 (Bethesda, Md.)|October 3, 2019
Genomics Analysis of L-DOPA Exposure in <i>Drosophila sechellia</i>Stephen M Lanno, Ivy Lam, Zachary Drum, et al.
Pageof 1